Search - tctmd.com

Displaying 641 - 653 of 653

Sort: Relevancy | Date

News Industry News

FDA Advisory Committee Recommends Approval of Oral Anticoagulant Rivaroxaban for the Prevention of Stroke and Systemic Embolism in Patients with Non-Valvular Atrial Fibrillation

September 08, 2011

News Daily News

Carbon Dioxide Angiography May Be Alternative to Iodinated Contrast in High-Risk Patients

L.A. McKeown

August 16, 2011

News Daily News

Early Morning Circadian Rhythms Linked to Stent Thrombosis

February 21, 2011

News Industry News

EKOS Corporation Receives CE Mark to Treat Massive and Sub-Massive Pulmonary Embolism

January 16, 2011

News Industry News

Bayer’s Rivaroxaban Submitted for EU Marketing Authorisation in Stroke Prevention in Patients with Atrial Fibrillation as well as for the Treatment of Deep Vein Thrombosis

January 04, 2011

Video

» Topical Discussion

Quick Takes: Nate Watson on Emergency Room Discharge Rates for Acute PE Patients

February 12, 2024

Video

» Interview

Outcomes for the Full US Cohort of the FLASH FlowTriever Mechanical Thrombectomy Registry in Pulmonary Embolism

September 19, 2022

Video

» Interview

A Prospective Multicenter Trial of Pharmaco-Mechanical Catheter-Directed Thrombolysis with the BASHIR™ Endovascular Catheter for Intermediate Risk Acute Pulmonary Embolism – The RESCUE Study

September 17, 2022

Partner Content

Real-world, Lytic-free Evidence for Treatment of Pulmonary Embolism with Inari Medical’s FlowTriever

November 6, 2021

Video

» Interview

FLASH Registry: Acute Hemodynamic Improvement With Percutaneous Mechanical Thrombectomy in a Real-world Pulmonary Embolism Population

October 18, 2020

BIO

Mahesh V. Madhavan, MD

Video

» Interview

TCT 2016: Dr. C. Michael Gibson talks with Dr. Duane Pinto and Dr. Tom Tu Kodali about Pulmonary Embolism

May 11, 2018

Advertisement

FDA Advisory Committee Recommends Approval of Oral Anticoagulant Rivaroxaban for the Prevention of Stroke and Systemic Embolism in Patients with Non-Valvular Atrial Fibrillation

Carbon Dioxide Angiography May Be Alternative to Iodinated Contrast in High-Risk Patients

Early Morning Circadian Rhythms Linked to Stent Thrombosis

EKOS Corporation Receives CE Mark to Treat Massive and Sub-Massive Pulmonary Embolism

Bayer’s Rivaroxaban Submitted for EU Marketing Authorisation in Stroke Prevention in Patients with Atrial Fibrillation as well as for the Treatment of Deep Vein Thrombosis

Quick Takes: Nate Watson on Emergency Room Discharge Rates for Acute PE Patients

Outcomes for the Full US Cohort of the FLASH FlowTriever Mechanical Thrombectomy Registry in Pulmonary Embolism

A Prospective Multicenter Trial of Pharmaco-Mechanical Catheter-Directed Thrombolysis with the BASHIR™ Endovascular Catheter for Intermediate Risk Acute Pulmonary Embolism – The RESCUE Study

Real-world, Lytic-free Evidence for Treatment of Pulmonary Embolism with Inari Medical’s FlowTriever

FLASH Registry: Acute Hemodynamic Improvement With Percutaneous Mechanical Thrombectomy in a Real-world Pulmonary Embolism Population

Mahesh V. Madhavan, MD

TCT 2016: Dr. C. Michael Gibson talks with Dr. Duane Pinto and Dr. Tom Tu Kodali about Pulmonary Embolism

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content